During the recent Milken Institute’s Future of Health Summit, Seema Verma, Centers for Medicare and Medicaid Services administrator, was critical of high prescription drug launch prices, Policy & Medicine reports.
“Now we have a half a million-dollar drug and $1 million drug and the question is: ‘When does that end?'” she said.
Verma was also cautious about giving the government more power to negotiate down drug prices.
To read more on Policy & Medicine, click here.